Regulators reject MDMA as treatment for PTSD, calling for more study
WASHINGTON (AP) — Federal health regulators have declined to approve the psychedelic drug MDMA as a therapy for PTSD, a setback for groups seeking a breakthrough decision in favor of using mind-altering substances to treat serious mental-health conditions. Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based [...]